Literature DB >> 21655924

p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.

Mozhgan Rasti1, Rita Arabsolghar, Zahed Khatooni, Zoherh Mostafavi-Pour.   

Abstract

p53 is a tumor suppressor protein that regulates estrogen receptor 1 (ESR1) expression. To investigate the mechanism of ESR1 gene regulation by p53, chromatin immunoprecipitation was applied to assess the binding of p53, DNMT1, HDAC1 and MeCP2 to both silenced ESR1 promoter in MDA-MB-468 cells and active ESR1 promoter in MCF-7 breast cancer cells. The results of chromatin immunoprecipitation experiments showed that p53 protein binds to both unmethylated CpG island of the ESR1 promoter in the ER-positive MCF-7 and the hypermethylated ESR1 promoter in the ER-negative MDA-MB-468 cells. However, repression complex including DNMT1, HDAC1 and MeCP2 is only associated with silenced ESR1 in ER-negative MDA-MB-468 human breast cancer cells. In addition, ectopically expressed wild type p53 failed to reactivate the ESR1 gene in these cells. These results suggest that specific p53 mutations may contribute to loss of estrogen receptor α expression in breast tumors and also support the hypothesis that mutant p53 is likely to impact DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21655924     DOI: 10.1007/s12253-011-9423-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  41 in total

1.  A global map of p53 transcription-factor binding sites in the human genome.

Authors:  Chia-Lin Wei; Qiang Wu; Vinsensius B Vega; Kuo Ping Chiu; Patrick Ng; Tao Zhang; Atif Shahab; How Choong Yong; YuTao Fu; Zhiping Weng; JianJun Liu; Xiao Dong Zhao; Joon-Lin Chew; Yen Ling Lee; Vladimir A Kuznetsov; Wing-Kin Sung; Lance D Miller; Bing Lim; Edison T Liu; Qiang Yu; Huck-Hui Ng; Yijun Ruan
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

2.  Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.

Authors:  X Yang; A T Ferguson; S J Nass; D L Phillips; K A Butash; S M Wang; J G Herman; N E Davidson
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition.

Authors:  Ariane Scoumanne; Xinbin Chen
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

4.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

Review 5.  The role of p53 in apoptosis.

Authors:  Joana D Amaral; Joana M Xavier; Clifford J Steer; Cecília M Rodrigues
Journal:  Discov Med       Date:  2010-02       Impact factor: 2.970

Review 6.  Epigenetic information and estrogen receptor alpha expression in breast cancer.

Authors:  Laura Giacinti; Pier Paolo Claudio; Massimo Lopez; Antonio Giordano
Journal:  Oncologist       Date:  2006-01

7.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Mapping of ER gene CpG island methylation-specific polymerase chain reaction.

Authors:  R G Lapidus; S J Nass; K A Butash; F F Parl; S A Weitzman; J G Graff; J G Herman; N E Davidson
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

10.  Divergent evolution of human p53 binding sites: cell cycle versus apoptosis.

Authors:  Monica M Horvath; Xuting Wang; Michael A Resnick; Douglas A Bell
Journal:  PLoS Genet       Date:  2007-06-15       Impact factor: 5.917

View more
  13 in total

1.  Discovery of Transcriptional Targets Regulated by Nuclear Receptors Using a Probabilistic Graphical Model.

Authors:  Mikyung Lee; Ruili Huang; Weida Tong
Journal:  Toxicol Sci       Date:  2015-12-07       Impact factor: 4.849

Review 2.  Environmental immune disruptors, inflammation and cancer risk.

Authors:  Patricia A Thompson; Mahin Khatami; Carolyn J Baglole; Jun Sun; Shelley A Harris; Eun-Yi Moon; Fahd Al-Mulla; Rabeah Al-Temaimi; Dustin G Brown; Annamaria Colacci; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Roslida A Hamid; Leroy Lowe; Tiziana Guarnieri; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

3.  Personalized characterization of diseases using sample-specific networks.

Authors:  Xiaoping Liu; Yuetong Wang; Hongbin Ji; Kazuyuki Aihara; Luonan Chen
Journal:  Nucleic Acids Res       Date:  2016-09-04       Impact factor: 16.971

4.  Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.

Authors:  Yi A Ren; Lisa K Mullany; Zhilin Liu; Alan J Herron; Kwong-Kwok Wong; JoAnne S Richards
Journal:  Cancer Res       Date:  2016-03-10       Impact factor: 12.701

5.  MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy.

Authors:  George C Bobustuc; Joshua S Smith; Sreeram Maddipatla; Sheila Jeudy; Arati Limaye; Beth Isley; Maria-Lourdes M Caparas; Susan M Constantino; Nikita Shah; Cheryl H Baker; Kalkunte S Srivenugopal; Said Baidas; Santhi D Konduri
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

6.  Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.

Authors:  Rita Arabsolghar; Tayebeh Azimi; Mozhgan Rasti
Journal:  Mol Biol Rep       Date:  2012-12-15       Impact factor: 2.316

7.  Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases.

Authors:  Lisa K Mullany; Zhilin Liu; Kwong-Kwok Wong; Victoria Deneke; Yi Athena Ren; Alan Herron; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2013-01-01

8.  MultiDCoX: Multi-factor analysis of differential co-expression.

Authors:  Herty Liany; Jagath C Rajapakse; R Krishna Murthy Karuturi
Journal:  BMC Bioinformatics       Date:  2017-12-28       Impact factor: 3.169

9.  Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.

Authors:  Andrew Sulaiman; Sarah McGarry; Ka Mien Lam; Sara El-Sahli; Jason Chambers; Shelby Kaczmarek; Li Li; Christina Addison; Jim Dimitroulakos; Angel Arnaout; Carolyn Nessim; Zemin Yao; Guang Ji; Haiyan Song; Sheng Liu; Ying Xie; Suresh Gadde; Xuguang Li; Lisheng Wang
Journal:  Cell Death Dis       Date:  2018-07-26       Impact factor: 8.469

10.  Functional Profiling of Human MeCP2 by Automated Data Comparison Analysis and Computerized Expression Pathway Modeling.

Authors:  Injoo Kim; Shin Hae Lee; Jinwoo Jeong; Jun Hyung Park; Mi Ae Yoo; Cheol Min Kim
Journal:  Healthc Inform Res       Date:  2016-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.